HER2-Positive Breast Cancer Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2021 - 2031

  • Single User License $3500

HER2-Positive Breast Cancer Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2021 - 2031

Status : November, 2022 | Pharmaceutical

Report Digest


HER2-Positive Breast Cancer Market – Overview

Human epidermal development factor receptor 2 (HER2) is a gene that is connected to breast cancer improvement. Genes contain the recipes for various proteins expected by a cell to stay solid and capacity typically. This protein animates cancer cell proliferation. Cancer cells in around one out of each and every five breast growths have additional duplicates of the gene that delivers the HER2 protein. Breast cancers that are HER2-positive are more forceful than different sorts of breast cancer. The increasing cases of breast cancer are projected to serve as the key growth driver for the global HER-2 positive breast cancer market. This is likely to continue in the forecast period set between 2021 and 2031 as well.

HER2-positive breast cancer is the second most normal cancer on the planet and the most widely recognized cancer in ladies around the world. Around 1 of 5 breast cancers are HER2-positive. HER2-positive breast cancer can be identified by FISH test, IHC test, biopsy, or CT scan. Human epidermal development factor receptor assists breast with separating, cells develop, and fix. Transformation in the HER2 quality that controls the HER2 protein makes such a large number of these receptors. Thus, the rising awareness about treating breast cancer and its positive success rates will also aid in favor of this market in the forecast period.

HER-2 positive breast cancer market survey offers insights into the market including drivers, restraints, challenges, and new growth opportunities. It also highlights the key innovations that made positive contribution to the market in terms of revenue generation. The impact of the novel COVID19 pandemic is also discussed in the report. Moreover, the list of players functioning in this market is also provided in the HER2-Positive Breast Cancer market survey, together with the current competitive nature. The report is available for sale on the company website.

HER2-Positive Breast Cancer Market – Competitive Landscape

The nature of the global HER2-Positive Breast Cancer market is fragmented on account of the presence of multiple players. Leading players in the HER2-Positive Breast Cancer market are emphasizing on adoption of growth strategies, such as innovations in the current technologies, joint ventures, mergers and acquisitions, and more to gain an upper hand in the market competition. Some other players are investing in research and development to ensure brand expansion and market dominance on the other.

Some of the key players of the global HER2-Positive Breast Cancer market include:

  • Fresenius Kabi AG
  • Baxter
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline plc,
  • Novartis AG
  • Merck & Co. Inc.
  • AstraZeneca
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd.
  • Eli Lily and Company
  • Bayer AG
  • Other players

HER2-Positive Breast Cancer Market – Innovation

  • The Food and Drug Administration (FDA) approved the launch of ado-trastuzumab emtansine by KADCYLA, Genetech Inc. in May 2019 to be used for treating patients with HER-2 positive early breast cancer or EBC.

HER2-Positive Breast Cancer Market – Growth Drivers

HER2-positive breast cancer has a Potential for new treatments a work in progress and many are as of now being tested. This is the central point adding to its market development. An expansion in the commonness pace of HER2-positive breast cancer joined to other clinical signs will aid in the growing demand for treating HER-2 positive breast cancer. During the COVID19 pandemic, this market witnessed a significant growth owing to the increasing demand for commonly used drugs such as Hydroxychloroquine. Both the biotechnology and biotechnology sectors witnessed notable growth owing to the increasing demand for treating positive breast cancer worldwide. Such factors will also add boost to the overall growth of this market in the forecast period.

HER2-Positive Breast Cancer Market – Geographical Insights

Regionwise, North America earned the largest share in the HER-2 positive breast cancer market on account of the presence of major players in the developed nations such as Canada and the United States. Besides this, the presence of well-established healthcare infrastructure along with the presence of well aware patient population will also create new growth opportunities for this regional market in the forecast period.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.